Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Prostate Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 104 articles: HTML format Text format

Single Articles

March 2010
1. PRINTZ C
   Common sexual infection linked to aggressive prostate cancer.
   Cancer. 2010;116:1395.
   PubMed     Text format     Related articles   
   
   
   
2. BERGMAN J , Chi AC, Litwin MS
   Quality of end-of-life care in low-income, uninsured men dying of prostate cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. CHADHA MK , Tian L, Mashtare T, Payne V, et al
   Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration-resistant prostate cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. WILKE DR , Krahn M, Tomlinson G, Bezjak A, et al
   Sex or survival: short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. CHOE KS , Correa D, Jani AB, Liauw SL, et al
   The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. GARZOTTO M , Higano CS, O'Brien C, Rademacher BL, et al
   Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. TAGAWA ST , Beltran H, Vallabhajosula S, Goldsmith SJ, et al
   Anti-prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer.
   Cancer. 2010;116.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. NGUYEN PL , Chen MH, Beard CJ, Suh WW, et al
   Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence.
   Cancer. 2010;116:610-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
9. TONI I , Flamini E, Mercatali L, Sacanna E, et al
   Pathogenesis of osteoblastic bone metastases from prostate cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. PARSONS JK , Kwan L, Connor SE, Miller DC, et al
    Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. VAN DEN BERGH RC , Steyerberg EW, Khatami A, Aus G, et al
    Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. DOSORETZ AM , Chen MH, Salenius SA, Ross RH, et al
    Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
13. DONNELLY BJ , Saliken JC, Brasher PM, Ernst SD, et al
    A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. LEE WR
    We need better randomized comparison trials of prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
15. MAJID S , Dar AA, Shahryari V, Hirata H, et al
    Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
16. BERGDAHL AG , Aus G, Lilja H, Hugosson J, et al
    Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. PRINTZ C
    Many unknowns in low-risk prostate cancer treatment.
    Cancer. 2009;115:4645-4646.
    PubMed     Text format     Related articles   
    
    
    
18. PRINTZ C
    Research continues into best ways to treat low-risk prostate cancer.
    Cancer. 2009;115:4431-2.
    PubMed     Text format     Related articles   
    
    
    September 2009
19. RAPITI E , Fioretta G, Schaffar R, Neyroud-Caspar I, et al
    Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. BRADLEY D , Rathkopf D, Dunn R, Stadler WM, et al
    Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and Univers
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. DENHAM JW , Steigler A, Wilcox C, Lamb DS, et al
    Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. ROBINSON JW , Donnelly BJ, Siever JE, Saliken JC, et al
    A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. WONG WW , Vora SA, Schild SE, Ezzell GA, et al
    Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. LIEBIG C , Ayala G, Wilks JA, Berger DH, et al
    Perineural invasion in cancer: a review of the literature.
    Cancer. 2009;115:3379-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
25. MOORE SC , Peters TM, Ahn J, Park Y, et al
    Age-specific physical activity and prostate cancer risk among white men and black men.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. LEVINSON AW , Ward NT, Pavlovich CP
    Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
27. CARPENTER WR , Godley PA, Clark JA, Talcott JA, et al
    Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. ABOUASSALY R , Paciorek A, Ryan CJ, Carroll PR, et al
    Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. VAN DEN BERGH RC , Essink-Bot ML, Roobol MJ, Wolters T, et al
    Anxiety and distress during active surveillance for early prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. MOSHER CE , Sloane R, Morey MC, Snyder DC, et al
    Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BERGMAN J , Gore JL, Saigal CS, Kwan L, et al
    Partnership and outcomes in men with prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. PRINTZ C
    Centers explore role of stress in health disparities.
    Cancer. 2009;115:3165.
    PubMed     Text format     Related articles   
    
    
    
33. GONG Z , Kristal AR, Schenk JM, Tangen CM, et al
    Alcohol consumption, finasteride, and prostate cancer risk: results from the prostate cancer prevention trial.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. TU SM , Lopez A, Leibovici D, Bilen MA, et al
    Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy.
    Cancer. 2009;115:2872-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. BANGMA CH , Roobol MJ, Steyerberg EW
    Predictive models in diagnosing indolent cancer.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. DONOVAN MJ , Costa J, Cordon-Cardo C
    Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. MONTIRONI R , Cheng L, Lopez-Beltran A, Mazzucchelli R, et al
    Decision support systems for morphology-based diagnosis and prognosis of prostate neoplasms: a methodological approach.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. BRIGANTI A , Capitanio U, Chun FK, Karakiewicz PI, et al
    Prediction of sexual function after radical prostatectomy.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. FIORINO C , Rancati T, Valdagni R
    Predictive models of toxicity in external radiotherapy: dosimetric issues.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. RIPAMONTI CI , Farina G, Garassino MC
    Predictive models in palliative care.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. TOUIJER K , Scardino PT
    Nomograms for staging, prognosis, and predicting treatment outcomes.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. DENIS LJ , Gospodarowicz MK
    Conclusions and reflections.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
43. VALDAGNI R , Scardino PT, Denis L
    The 2008 European School of Oncology inside Track Conference, "Predictive Modeling in Prostate Cancer"
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. 
    Predictive Modeling in Prostate Cancer.
    Cancer. 2009;115.
    PubMed     Text format     Related articles   
    
    
    
45. HERMAN MP , Dorsey P, John M, Patel N, et al
    Techniques and predictive models to improve prostate cancer detection.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. LOPERGOLO A , Zaffaroni N
    Biomolecular markers of outcome prediction in prostate cancer.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. FEBBO PG
    Genomic approaches to outcome prediction in prostate cancer.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. NGUYEN CT , Kattan MW
    Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. VALDAGNI R , Rancati T, Fiorino C
    Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. NGUYEN CT , Zelefsky MJ, Kattan MW
    The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. ROACH M 3RD , Waldman F, Pollack A
    Predictive models in external beam radiotherapy for clinically localized prostate cancer.
    Cancer. 2009;115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. HIGANO CS , Schellhammer PF, Small EJ, Burch PA, et al
    Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. AKAZA H , Hinotsu S, Usami M, Arai Y, et al
    Combined androgen blockade with bicalutamide for advanced prostate cancer: long-Term Follow-Up of a Phase 3, Double-Blind, Randomized Study for Survival.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. MCLAFFERTY S , Wang F
    Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois.
    Cancer. 2009;115:2755-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. WANG R , Chinnaiyan AM, Dunn RL, Wojno KJ, et al
    Rational approach to implementation of prostate cancer antigen 3 into clinical care.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
56. BRIA E , Cuppone F, Giannarelli D, Milella M, et al
    Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-Analysis of Randomized Trials.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. MOUL JW
    Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
58. SATOH T , Kimura M, Matsumoto K, Tabata KI, et al
    Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. LIN DW , Porter M, Montgomery B
    Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. SCHECTER A , Needham L, Pavuk M, Michalek J, et al
    Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    April 2009
61. TAYLOR LG , Canfield SE, Du XL
    Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. MELIKER JR , Goovaerts P, Jacquez GM, Avruskin GA, et al
    Breast and prostate cancer survival in Michigan: can Geographic Analyses Assist in Understanding Racial Disparities?
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
63. HALBERT CH , Weathers B, Delmoor E, Mahler B, et al
    Racial differences in medical mistrust among men diagnosed with prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. POLASCIK TJ , Mayes JM, Schroeck FR, Sun L, et al
    Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. LIPPI G , Montagnana M, Guidi GC
    Epidemiological association between C-reactive protein and prostate-specific antigen.
    Cancer. 2009;115:1132.
    PubMed     Text format     Related articles   
    
    
    February 2009
66. PHAN J , Swanson DA, Levy LB, Kudchadker RJ, et al
    Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. LIAUW SL , Fricano J, Correa D, Weichselbaum RR, et al
    Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. CROOK JM , Malone S, Perry G, Eapen L, et al
    Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial.
    Cancer. 2009;115:673-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
69. KATTAN MW , Vickers AJ, Yu C, Bianco FJ, et al
    Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. CHOUEIRI TK , Xie W, D'Amico AV, Ross RW, et al
    Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. EGGENER SE , Vickers AJ, Serio AM, Donovan MJ, et al
    Comparison of models to predict clinical failure after radical prostatectomy.
    Cancer. 2009;115:303-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. ALIBHAI SM , Leach M, Warde P
    Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.
    Cancer. 2009;115:293-302.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. VUKY J , Porter C, Isacson C, Vaughan M, et al
    Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
74. KELLY WK , Halabi S, Elfiky A, Ou SS, et al
    Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer : results of Cancer and Leukemia Group B 99811.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. OEFELEIN MG
    Androgen suppression therapy and prostate cancer : balancing the harms and the benefits.
    Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
76. D'AMICO AV , Chen MH, Renshaw AA, Loffredo M, et al
    Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
77. DAVIS JW
    Screening for prostate cancer with serum prostate-specific antigen : what should we recommend while waiting for randomized clinical trial results?
    Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
78. NGUYEN PL , Chen MH, Catalona WJ, Alexander BM, et al
    Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer : implications for management.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. COOPERBERG MR
    Prostate cancer risk assessment: choosing the sharpest tool in the shed.
    Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
80. WALZ J , Haese A, Scattoni V, Steuber T, et al
    Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. SCHULTE RT , Wood DP, Daignault S, Shah RB, et al
    Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy.
    Cancer. 2008;113:1559-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. INMAN BA , Davies JD, Rangel LJ, Bergstralh EJ, et al
    Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL.
    Cancer. 2008;113:1544-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
83. SHARIAT SF , Karakiewicz PI, Roehrborn CG, Kattan MW, et al
    An updated catalog of prostate cancer predictive tools.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SCHROECK FR , Donatucci CF, Smathers EC, Sun L, et al
    Defining potency: A comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. MASTALSKI K , Coups EJ, Ruth K, Raysor S, et al
    Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. MIERZWA ML , Barrett WL, Redmond K, Shirazi R, et al
    Randomized trial to assess the efficacy of intraoperative steroid use in decreasing acute urinary retention after transperineal radioactive iodine-125 implantation for prostate cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. SPAIN P , Carpenter WR, Talcott JA, Clark JA, et al
    Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. HATOUM HT , Lin SJ, Smith MR, Barghout V, et al
    Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database.
    Cancer. 2008;113:1438-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. SCALES CD JR , Antonelli J, Curtis LH, Schulman KA, et al
    Prostate-specific antigen screening among young men in the United States.
    Cancer. 2008;113:1315-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. NADLER RB
    The case for prostate-specific antigen screening starting at age 40.
    Cancer. 2008;113:1278-81.
    PubMed     Text format     Related articles   
    
    
    
91. SUARDI N , Capitanio U, Chun FK, Graefen M, et al
    Currently used criteria for active surveillance in men with low-risk prostate cancer: An analysis of pathologic features.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. NELSON JB , Love W, Chin JL, Saad F, et al
    Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. DAWSON NA
    Targeted therapy in prostate cancer-Are we our own worst enemy?
    Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
94. SINGER EA , Palapattu GS, van Wijngaarden E
    Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
95. TANEJA SS , Tareen B
    Targeting prostate cancer for focal destruction: can we find it?
    Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
96. HENDERSON JA , Espey DK, Jim MA, German RR, et al
    Prostate cancer incidence among American Indian and Alaska Native men, US, 1999-2004.
    Cancer. 2008;113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MARTIN NE , Chen MH, Catalona WJ, Loeb S, et al
    The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis.
    Cancer. 2008;113:717-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. SOMMERS BD , Beard CJ, D'Amico AV, Kaplan I, et al
    Predictors of patient preferences and treatment choices for localized prostate cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
99. CHAMIE K , Devere White RW, Volpp B, Lee D, et al
    Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. NELSON CJ , Lee JS, Gamboa MC, Roth AJ, et al
     Cognitive effects of hormone therapy in men with prostate cancer: a Review.
     Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. SHAH SR , Terris MK
     Editorial comment on: Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
     Cancer. 2008.
     PubMed     Text format     Related articles   
     
     
     
102. GIGNAC GA , Morris MJ, Heller G, Schwartz LH, et al
     Assessing outcomes in prostate cancer clinical trials: a twenty-first century Tower of Babel.
     Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. HIGANO CS , Corman JM, Smith DC, Centeno AS, et al
     Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.
     Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
104. GIORDANO SH , Kuo YF, Duan Z, Hortobagyi GN, et al
     Limits of observational data in determining outcomes from cancer therapy.
     Cancer. 2008;112:2456-66.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: